Compile Data Set for Download or QSAR
Report error Found 10 of ic50 data for complexid = 219
TargetVascular endothelial growth factor receptor 1/2(Human)
Astex Therapeutics

US Patent
LigandPNGBDBM381830(US10272087, Compound 13 | US10272087, Compound 2)
Affinity DataIC50: 25.1nMAssay Description:In a final reaction volume of 30 μL, KDR (h) (150 ng/ml) was incubated with 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.1 mM Na3VO4, 0.01% Trito...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetVascular endothelial growth factor receptor 1/2(Human)
Astex Therapeutics

US Patent
LigandPNGBDBM381829(US10272087, Compound 11 | US10272087, Compound 1)
Affinity DataIC50: 100nMAssay Description:In a final reaction volume of 30 μL, KDR (h) (150 ng/ml) was incubated with 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.1 mM Na3VO4, 0.01% Trito...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetVascular endothelial growth factor receptor 1/2(Human)
Astex Therapeutics

US Patent
LigandPNGBDBM381830(US10272087, Compound 13 | US10272087, Compound 2)
Affinity DataIC50: 251nMAssay Description:In a final reaction volume of 30 μL, KDR (h) (150 ng/ml) was incubated with 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.1 mM Na3VO4, 0.01% Trito...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetVascular endothelial growth factor receptor 1/2(Human)
Astex Therapeutics

US Patent
LigandPNGBDBM381835(US10272087, Compound 9)
Affinity DataIC50: 398nMAssay Description:In a final reaction volume of 30 μL, KDR (h) (150 ng/ml) was incubated with 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.1 mM Na3VO4, 0.01% Trito...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetVascular endothelial growth factor receptor 1/2(Human)
Astex Therapeutics

US Patent
LigandPNGBDBM381834(US10272087, Compound 8)
Affinity DataIC50: 794nMAssay Description:In a final reaction volume of 30 μL, KDR (h) (150 ng/ml) was incubated with 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.1 mM Na3VO4, 0.01% Trito...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetVascular endothelial growth factor receptor 1/2(Human)
Astex Therapeutics

US Patent
LigandPNGBDBM381831(US10272087, Compound 3)
Affinity DataIC50: 1.00E+3nMAssay Description:In a final reaction volume of 30 μL, KDR (h) (150 ng/ml) was incubated with 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.1 mM Na3VO4, 0.01% Trito...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetVascular endothelial growth factor receptor 1/2(Human)
Astex Therapeutics

US Patent
LigandPNGBDBM381832(US10272087, Compound 4)
Affinity DataIC50: 1.00E+3nMAssay Description:In a final reaction volume of 30 μL, KDR (h) (150 ng/ml) was incubated with 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.1 mM Na3VO4, 0.01% Trito...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetVascular endothelial growth factor receptor 1/2(Human)
Astex Therapeutics

US Patent
LigandPNGBDBM381833(US10272087, Compound 7)
Affinity DataIC50: 1.00E+3nMAssay Description:In a final reaction volume of 30 μL, KDR (h) (150 ng/ml) was incubated with 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.1 mM Na3VO4, 0.01% Trito...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetVascular endothelial growth factor receptor 1/2(Human)
Astex Therapeutics

US Patent
LigandPNGBDBM381836(US10272087, Compound 10)
Affinity DataIC50: 1.00E+3nMAssay Description:In a final reaction volume of 30 μL, KDR (h) (150 ng/ml) was incubated with 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.1 mM Na3VO4, 0.01% Trito...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetVascular endothelial growth factor receptor 1/2(Human)
Astex Therapeutics

US Patent
LigandPNGBDBM381829(US10272087, Compound 11 | US10272087, Compound 1)
Affinity DataIC50: 1.00E+3nMAssay Description:In a final reaction volume of 30 μL, KDR (h) (150 ng/ml) was incubated with 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.1 mM Na3VO4, 0.01% Trito...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent